Proneuron Biotechnologies' Series C Round

Proneuron Biotechnologies raised a round of funding on July 14, 2004. Investors include DFJ Tamir Fishman Ventures.

Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.…

Articles about Proneuron Biotechnologies' Series C Round: